By posting this I am not necessarily advocating this treatment just trying to find out more information on how it is made and how it is administered
Gene therapy AB-1005 found safe in Phase 1b Parkinson’s trial
parkinsonsnewstoday.com/new...
fiercebiotech.com/biotech/b....
AB-1005 was administered to the brain via one-time bilateral convection-enhanced delivery. The main goal was to evaluate the safety and potential clinical effect of the treatment.
"AB-1005 is an investigational gene therapy based on adeno-associated viral vector serotype 2 (AAV2) containing the human glial cell line-derived neurotrophic factor (GDNF) transgene, which allows for stable and continuous expression of GDNF in localized regions of the brain after direct neurosurgical injection with MRI ...
Convection enhanced delivery